Second, we only performed common tumor phenotype experiments, and we did not perform Bulk sequencing on knockdown cell lines, so the more specific downstream pathways of AGPAT5, LCLAT1, and LPCAT1 and their biological mechanisms still need to be investigated in depth, which will be further explored in our future work. The gene discussed is LCLAT1; the disease is neoplasm.